HBW Advisory Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,585
Closed -$211K 221
2022
Q1
$211K Sell
4,585
-8,918
-66% -$425K 0.07% 205
2021
Q4
$827K Buy
13,503
+629
+5% +$43.5K 0.19% 123
2021
Q3
$962K Buy
12,874
+1,429
+12% +$120K 0.25% 99
2021
Q2
$1.06M Buy
11,445
+2,184
+24% +$186K 0.28% 91
2021
Q1
$822K Buy
9,261
+5,411
+141% +$537K 0.22% 108
2020
Q4
$359K Sell
3,850
-180
-4% -$14.3K 0.11% 147
2020
Q3
$257K Buy
+4,030
New +$236K 0.11% 158

Other funds holding ARKG

HBW Advisory Services's ARKG Position: Q2 2022 in Review

HBW Advisory Services sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 4,585 shares — an estimated $211K sold.

HBW Advisory Services first reported a position in ARKG in Q3 2020 and held it in 7 quarters. The position peaked at $1.06M in Q2 2021. 334 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

  • HBW Advisory Services reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
  • HBW Advisory Services sold 4,585 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $211K.
  • HBW Advisory Services first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 7 quarters.
  • HBW Advisory Services's ARK Genomic Revolution ETF position peaked at $1.06M in Q2 2021.
  • 334 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on HBW Advisory Services's 13F filing for Q2 2022, filed 13 Jul 2022.